0029| Volume 128, SUPPLEMENT , 154991, March 2022

The Association Between Adiponectin and Myocardial Infarction in Patients with Nonalcoholic Fatty Liver Disease

      Background: Adiponectin is an adipocyte-specific secretory protein that is highly expressed in adipose tissue. Adiponectin levels are decreased in patients with metabolic diseases, such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). NAFLD has been associated with an increased risk of myocardial infarction (MI) in previous studies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect